Moleculin Biotech (MBRX) Insider Trading & Ownership $1.82 +0.09 (+5.20%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Moleculin Biotech (NASDAQ:MBRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.10%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$159,990.30Number OfInsiders Selling(Last 12 Months)0 Get MBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MBRX Insider Buying and Selling by Quarter Ad Behind the Markets$19 for a FULL YEAR of stock picks?!We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $19. But why? Because there is a very small window of time... as little as 25 days from now... That will change the market forever.Click here to get in now>>> Moleculin Biotech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/26/2023Jonathan P FosterCFOBuy1,932$10.35$19,996.20 12/26/2023Robert E GeorgeDirectorBuy966$10.35$9,998.10 12/26/2023Walter V KlempCEOBuy12,560$10.35$129,996.00 (Data available from 1/1/2013 forward) MBRX Insider Trading Activity - Frequently Asked Questions Who is on Moleculin Biotech's Insider Roster? The list of insiders at Moleculin Biotech includes Jonathan P Foster, Robert E George, and Walter V Klemp. Learn more on insiders at MBRX. What percentage of Moleculin Biotech stock is owned by insiders? 7.10% of Moleculin Biotech stock is owned by insiders. Learn more on MBRX's insider holdings. Which Moleculin Biotech insiders have been buying company stock? The following insiders have purchased MBRX shares in the last 24 months: Jonathan P Foster ($19,996.20), Robert E George ($9,998.10), and Walter V Klemp ($129,996.00). How much insider buying is happening at Moleculin Biotech? Insiders have purchased a total of 15,458 MBRX shares in the last 24 months for a total of $159,990.30 bought. Moleculin Biotech Key ExecutivesMr. Walter V. Klemp (Age 64)Founder, Chairman, President & CEO Compensation: $894.54kMr. Jonathan P. Foster CPA (Age 60)Executive VP & CFO Compensation: $611.17kDr. Donald H. Picker Ph.D. (Age 78)Chief Scientific Officer Compensation: $486.44kDr. Waldemar Priebe Ph.D.Co-Founder, Founding Scientist & Chairman of Scientific Advisory BoardDr. John Paul Waymack M.D. (Age 72)Sc.D., Senior Chief Medical Officer Dr. Sandra L. Silberman M.D. (Age 69)Ph.D., Chief Medical Officer of New Products Dr. Wolfram C. M. Dempke M.B.A.M.D., Ph.D., European Chief Medical OfficerMs. Jacqueline Northcut (Age 62)Consultant Compensation: $51.11kMr. Louis Ploth Jr. (Age 70)Independent Advisor Compensation: $118.49k More Insider Trading Tools from MarketBeat Related Companies GeoVax Labs Insider Ownership Athira Pharma Insider Ownership Bullfrog AI Insider Ownership Pieris Pharmaceuticals Insider Ownership IN8bio Insider Ownership MIRA Pharmaceuticals Insider Ownership Finch Therapeutics Group Insider Ownership Cyclo Therapeutics Insider Ownership Calidi Biotherapeutics Insider Ownership NRx Pharmaceuticals Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:MBRX) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
